FDA Heads to Court to Defend Unprecedented Decision Protecting Lung Drug Monopoly From Liquidia Competition - Hunterbrook Media
William Garvin, shareholder and co-chair of the firm's FDA section, was quoted in a Hunterbrook Media article entilted "FDA Heads to Court to Defend Unprecedented Decision Protecting Lung Drug Monopoly From Liquidia Competition."
Contributors
Related Services & Industries